Health~Holland International

2nd Annual Rare Disease Day: Translating Research from Academic Labs into a Therapy Join us to learn more about the rare disease landscape in the Netherlands and translating research through collaboration between academia and industry! Wednesday, April 2nd 13:00-17:30 CET Buruma Lecture Hall, LUMC Building 3 Leiden, Netherlands RSVP here: https://lnkd.in/eqCM-HFS We are honored to be joined by the following guest speakers: Arno Bisschop, MD/PhD, CEO, Genewity B.V. Ilan Ganot, MBA, CEO, Alesta Therapeutics Edward M. Kaye, MD, CEO, Stoke Therapeutics Carl Kilander, MD/PhD, Partner, HealthCap Tjitske Kleefstra MD/PhD, Department of Clinical Genetics, Erasmus MC Nael Nadif Kasri, Medical Sciences Faculty, Radboudumc Geoff Rhyne, CEO, IDefine-The Kleefstra Syndrome Foundation Kasper Roet, PhD, CEO QurAlis Andreas Schuil, MBA, General Manager, BeNeLux & Head of Partner Markets, EMEA, Orchard Therapeutics - U.S. Frank Staal, PhD, Department of Immunology, Leiden University Medical Center Mariette van der Velden-Roesink, MSc, Managing Partner, Curie Capital BV Edward van Wezel, MSc, Managing Partner, BGV (BGV (BioGeneration Ventures)) Organized by: Imran Ganda, Erica Mawby-Roche, Gijs Santen, Hans Schikan, & Yael Weiss Event is presented by: Health~Holland, Leiden University Medical Center, Mahzi Therapeutics, & The Termeer Foundation

🚀 Early Disease Detection is the Future – and It’s Happening NOW 🚀 Every year, millions lose their lives—not because treatments don’t exist, but because diseases are diagnosed too late. Cancer survival rates drop from 90%+ when caught early to less than 20% in advanced stages. Cardiovascular disease accounts for 32% of global deaths. But what if we could catch diseases before symptoms even appear? That’s exactly what You2Yourself (Y2Y) is doing. Founded by Bram De Moor & Johan de Rooij, Y2Y is revolutionizing healthcare with biomarker-based monitoring and AI-driven diagnostics. Their Urimon study now includes 5,000+ participants and 200,000+ blood & urine samples, leading to 85% sensitivity across 9 disease panels. 💡 As Bram de Moor puts it: "No one should have to fight an illness that could have been diagnosed far earlier. Our goal is to shift healthcare from reactive to proactive, giving people a real chance at a healthier future." Now, Y2Y is expanding into the US market—and they need the right partners to make it happen. If you're an investor, healthcare leader, or researcher, (or you know someone who is!) this is your moment to be part of something game-changing! 📢 Read the full story & get involved below: #HealthcareInnovation #EarlyDetection #Biotech #InvestInHealth #USAexpansion Health~Holland, Marianne van der Steen Ph.D., Mahrou Kharazi, Health~Holland International, American Chamber of Commerce to the European Union (AmCham EU) European American Chamber of Commerce and Industry Netherlands Consulate in San Francisco, J.P. Morgan

SAVE THE DATE 🗓️  March 13 - Expo Event Rotterdam 📍 After all the preparations, the World Expo in Japan 🇯🇵 is kicking off in April 2025! For six months, Expo 2025 Osaka will offer opportunities to explore new markets and connect with potential business partners. The Netherlands will have a stunning pavilion and participate with various sectors and missions. One month before, on March 13, you’ll receive the latest updates before our journey to Expo 2025 Osaka begins! The program includes interviews with track leaders from the participating sectors. We will guide you through what to expect from the LSH track. The Minister for Foreign Trade and Development Cooperation, Reinette Klever, will speak at the event. Additionally, Japanese Ambassador Hiroshi Minami will deliver a speech. You’ll also be taken on a virtual tour of the Dutch pavilion. Finally, there will be a networking reception where you can meet other entrepreneurs joining the mission to Japan. Find all the details here: https://lnkd.in/e4zaZrBa When? Thursday, March 13, 2025, from 2:30 PM to 6:00 PM (doors open at 2:00 PM). Where? Rotterdam Registration is now open: https://lnkd.in/eiXAyGbM NLExpo2025 - Netherlands participation at Expo 2025 Osaka Kansai

Are you looking to expand your business to the U.S.? ✨ The US Embassy The Hague is hosting an exclusive event at the High Tech Campus Eindhoven to help Dutch businesses explore opportunities in the U.S. market. With 15 U.S. states participating, attendees can gain valuable insights, build connections, and pre-schedule meetings to make the most of their visit. Don’t miss this opportunity - click the link to learn more and register! https://lnkd.in/eRrj2BGE

We are excited to announce our partnership with Galapagos to take decentralized CAR-T cell manufacturing in Europe to the next level! Together, we’re breaking new ground to accelerate access to potentially life-changing therapies. Full press release 👇   Leiden, Netherlands – February 10, 2025 – NecstGen, a leading Contract Development and Manufacturing Organization (CDMO) dedicated to Cell and Gene Therapies, is proud to announce a strategic collaboration with Galapagos NV (Euronext & NASDAQ: GLPG), a biotechnology company with operations in Europe and the U.S. to support decentralized manufacturing of Galapagos’ candidate cell therapy products. The partnership underscores both NecstGen’s and Galapagos’ commitment to advancing innovative therapies and bridging the gap between the translation of research, to large clinical trials, and bring products to patients.   Building on NecstGen’s expertise in GMP-compliant manufacturing and its cleanroom infrastructure, this collaboration will leverage part of its large state-of-the-art facilities to establish robust CAR-T manufacturing on the basis of Galapagos’ innovative decentralized manufacturing platform. The project aims to support decentralised production of CAR-T therapies, increasing accessibility of these potential lifesaving treatments to patients.   Galapagos is building a pipeline of potentially best-in-class candidate cell therapy products in hematological and solid tumors using its innovative decentralized manufacturing platform. This platform is designed to deliver fresh, fit, stem-like early cells in a median vein-to-vein time of seven days, thereby avoiding cryopreservation and eliminating the need for bridging therapy. The first product to be manufactured under the collaboration agreement will be GLPG5101 which targets relapsed/refractory non-Hodgkin lymphoma indications. The collaboration could be broadened to include the manufacturing of additional product candidates in Galapagos’ portfolio.   Under this agreement, NecstGen will use some of its cleanrooms to support manufacturing for Galapagos' clinical CAR-T programs. NecstGen will collaborate closely with Galapagos’ technical teams to ensure seamless and timely technology transfer and meet high production standards.   Paul Bilars, CEO of NecstGen, commented: "Our collaboration with Galapagos marks an exciting milestone in the evolution of NecstGen as an organisation and for Cell and Gene Therapy manufacturing. By combining our state-of-the-art infrastructure with Galapagos’ decentralized cell therapy approach, we aim to provide capacity  and support for decentralised manufacturing and make transformative therapies more accessible to patients who need them."    For more information connect with Tristan Pritchard-Meaker Netherlands Enterprise Agency , Netherlands Foreign Investment Agency, Leiden Bio Science Park, RegMed XB, Leiden University - Institute of Public Administration, Netherlands Society of Gene and Cell Therapy NVGCT

Active in digital health? Don’t miss the Economic Life Sciences & Health Mission to Japan and Expo 2025 Osaka! 🇳🇱 🇯🇵 By participating in this LSH mission you will:   - Take part in B2B matchmaking sessions; - Gain insights into the Japanese market, developments, and requirements; Take part in ecosystem sessions; - Visit i.a. Tokyo University and Biocommunity Kansai (BioCK) - Showcase your innovations and explore collaborations with Japan's advanced technological landscape; - Explore the Dutch pavilion at Expo 2025 Osaka and the Japan Health Exhibition. 🗓️ When: 22 - 28 June 2025 📍Where: Osaka & Tokyo ✍ Registration deadline: Wed, Feb 26 Have a look at the one-pager below for more info or: https://lnkd.in/eqUXDHrf #RegenerativeMedicine #healthyAging, #DigitalHealthcare, #Sports #Vitality #NetherlandsPavilion #Expo2025 #CommonGround #NL #InnovationMeetsCollaboration #GlobalOpportunities   Netherlands Foreign Investment Agency, Health~Holland, Task Force Health Care (TFHC), NLExpo2025 - Netherlands participation at Expo 2025 Osaka Kansai

Recap of this week's Roundtable in Sweden 🇸🇪 This Roundtable was organized with the aim to bring together Dutch and Swedish experts to identify concrete actions and key challenges that enhance bilateral cooperation and position both countries as European leaders in Advanced Therapy Medicinal Products (ATMP's) innovation. Our colleagues had the honor of presenting our Organ-on-Chip project and sharing insights on our role in promoting collaboration. 🤝 🌍 Key is that we are both small, smart nations, and working together can lead to great impact. Discussions about cross-border partnerships, joint funding, and regulatory alignment, with a focus on how Sweden’s Life Sciences Strategy and the Netherlands’ innovation ecosystem can accelerate clinical implementation, valorisation of excellent research and patient access are needed to get to this envisioned impact. To be continued... #ATMPs #Collaboration #Innovation #HealthHolland #PrecisionMedicine #OrganOnChip #Dutchambassy #Sweden #TheNetherlands

𝐑𝐞𝐠𝐢𝐬𝐭𝐫𝐚𝐭𝐢𝐨𝐧 𝐨𝐩𝐞𝐧! 📍 Economic Life Sciences & Health (LSH) Mission to Japan and Expo 2025 Osaka 🗓️ 22 - 28 june 2025 🤝 Participation is open to Dutch companies, knowledge institutions, start-ups, and scale-ups that are active in one of the following LSH themes. ✍ Sign-up here: https://lnkd.in/eqUXDHrf Are you active in: Digital healthcare, Regenerative medicine, Healthy aging, or Sports and vitality? And are you curious about business opportunities in the Japanese Life Sciences & Health (LSH) sector? Then sign up for this mission to Tokyo and Osaka! This mission takes place during the LSH week of the Expo 2025 Osaka and also includes a visit to the Japan Health Exhibition. Fleur Agema, Minister for Health, Welfare, and Sport, will attend part of the mission program. Carmen van Vilsteren, Chair of Top Sector LSH, is business delegation lead. The mission program includes both joint and sector-specific components. Sector-specific components may take place simultaneously and depend on the number of registrations per theme. See the one-pagers below for sector-specific information! 🔬 #NetherlandsPavilion #Expo2025 #CommonGround #NL #InnovationMeetsCollaboration #EventSpace #GlobalOpportunities NLExpo2025 - Netherlands participation at Expo 2025 Osaka Kansai, Embassy of the Kingdom of the Netherlands in Japan, Rijksdienst voor Ondernemend Nederland (RVO), オランダ経済省 企業誘致局 (NFIA Japan), Ministerie van Economische Zaken, Ministerie van Buitenlandse Zaken, ROM-Nederland, Ministerie van Volksgezondheid, Welzijn en Sport, Task Force Health Care (TFHC), Health~Holland

🇺🇸 Life Sciences & Health Mission to Los Angeles 🇺🇸 In just 2 weeks, a Dutch Delegation will be heading to Los Angeles (USA) for the Life Sciences & Health (LSH) Mission. Our objective? To foster innovation, collaboration, and knowledge exchange between Dutch and American healthcare sectors💡🏨. Key highlights of our visit: -         Networking with industry leaders and innovators -         Showcasing Dutch expertise in LSH -         Building lasting partnerships for future collaborations The Dutch Delegation consisting of Brabantse Ontwikkelings Maatschappij (BOM), Briddge Legal & Finance, Elevate, EW2Health B.V. (Easy Way to Health), Incision, LeQuest, @SensoniQ, Super Family, THAUMATEC TECH GROUP, TNO, Turacoz Group , and Wittenburg Group will visit industry leaders, innovators, and key healthcare professionals at among others Cedars-Sinai, Biocom California, Kaiser Permanente, and UCLA. Building on the mission’s momentum, we’re excited to collaborate with the Cedars-Sinai x NBSO Los Angeles x ScaleNL: HealthTech Mini-Accelerator 2025, amplifying our networking and innovation potential in the LA healthcare system. Last call for interested organizations: There's still a chance to join this exciting program! Don't miss out on this unique opportunity to be part of shaping the future of healthcare. Please reach out to me via daphne.elberse@tfhc.nl if you’re interested to join! Netherlands Enterprise Agency | NBSO Los Angeles | Task Force Health Care (TFHC)

Will we see you at the ICT&health World Conference 2025? We will be present with a Health~Holland stand! You're welcome to visit our stand to learn more about the Dutch LSH ecosystem and discover how Health~Holland can support you.📍 From January 28 to 30, 2025, the second edition of this groundbreaking conference will take place at the MECC Maastricht, building on the success of its inaugural edition. This conference brings together policymakers, executives, healthcare professionals, IT experts, program managers, investors, visionaries, and innovators from around the world. Join us to explore the latest developments, share valuable insights, and collaboratively shape the future of healthcare. More information: https://lnkd.in/e-72kagw Registration is possible here: https://lnkd.in/gGREjHJe